首站-论文投稿智能助手
典型文献
Association between sleep duration and incidence of type 2 diabetes in China: the REACTION study
文献摘要:
Backgrounds::Inadequate sleep duration is associated with a higher risk of type 2 diabetes and the relationship is nonlinear. We aim to assess the curve relationship between night sleep duration and the incidence of type 2 diabetes in China.Methods::A cohort of 11,539 participants from the REACTION study without diabetes at baseline (2011) were followed until 2014 for the development of type 2 diabetes. The average number of hours of sleep per night was grouped. Incidence rates and odds ratios (ORs) were calculated for the development of diabetes in each sleep duration category.Results::Compared to people who sleep for 7 to 8 h/night, people with longer sleep duration (≥9 h/night) had a greater risk of type 2 diabetes (OR: 1.27; 95% CI: 1.01-1.61), while shorter sleep (<6 h/night) had no significant difference in risk of type 2 diabetes. When the dataset was stratified based on selected covariates, the association between type 2 diabetes and long sleep duration became more evident among individuals <65 years of age, male, body mass index <24 kg/m 2 or with hypertension or hyperlipidemia, no interaction effects were observed. Furthermore, compared to people persistently sleeping 7 to 9 h/night, those who persistently slept ≥9 h/night had a higher risk of type 2 diabetes. The optimal sleep duration was 6.3 to 7.5 h/night. Conclusions::Short or long sleep duration was associated with a higher risk of type 2 diabetes. Persistently long sleep duration increased the risk.
文献关键词:
Sleep duration;Type 2 diabetes;Prevalence;Risk
作者姓名:
Liu Hongzhou;Chen Gang;Wen Junping;Wang Anping;Mu Yimin;Dou Jingtao;Gu Weijun;Zang Li;Zhang Saichun;Lyu Zhaohui
作者机构:
Department of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China;Department of Endocrinology, Fujian Provincial Hospital, Key Laboratory of Endocrinology, Fujian Medical University, Fuzhou, Fujian 350001, China
引用格式:
[1]Liu Hongzhou;Chen Gang;Wen Junping;Wang Anping;Mu Yimin;Dou Jingtao;Gu Weijun;Zang Li;Zhang Saichun;Lyu Zhaohui-.Association between sleep duration and incidence of type 2 diabetes in China: the REACTION study)[J].中华医学杂志(英文版),2022(10):1242-1248
A类:
Backgrounds,Inadequate,slept,Persistently
B类:
Association,between,duration,incidence,type,diabetes,China,REACTION,study,associated,higher,risk,relationship,nonlinear,We,aim,assess,curve,night,Methods,cohort,participants,from,without,baseline,were,followed,until,development,average,number,hours,was,grouped,Incidence,rates,odds,ratios,ORs,calculated,each,category,Results,Compared,people,who,longer,had,greater,while,shorter,significant,difference,When,dataset,stratified,selected,covariates,association,became,evident,among,individuals,years,male,body,mass,m ,hypertension,hyperlipidemia,interaction,effects,observed,Furthermore,compared,persistently,sleeping,those,optimal,Conclusions,Short,increased,Sleep,Type,Prevalence,Risk
AB值:
0.437433
相似文献
To"tell or not to tell"-Exploring disclosure about medicine use by people living with sleep disorders
Vibha Malhotra;Joanna Harnett;Erica McIntyre;Arnie Steel;Keith Wong;Bandana Saini-School of Pharmacy,Faculty of Medicine and Health,the University of Sydney,Sydney,New South Wales 2006,Australia;The Australian Research Centre in Complementary and Integrative Medicine,School of Public Health,the University of Technology,Sydney,New South Wales 2007,Australia;Institute for Sustainable Futures,the University of Technology,Sydney,New South Wales 2007,Australia;The Woolcock Institute of Medical Research,the University of Sydney,Sydney,New South Wales 2037,Australia;Sydney Medical School,Faculty of Medicine and Health,the University of Sydney,Sydney,New South Wales 2006,Australia;Department of Respiratory&Sleep Medicine,Royal Prince Alfred Hospital,Camperdown,New South Wales 2050,Australia
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
Association of baseline hemoglobin A1c levels with bleeding in patients with non-ST-segment elevation acute coronary syndrome underwent percutaneous coronary intervention:insights of a multicenter cohort study from China
Hua-Lin FAN;Li-Huan ZENG;Peng-Yuan CHEN;Yuan-Hui LIU;Chong-Yang DUAN;Wen-Fei HE;Ning TAN;Ji-Yan CHEN;Peng-Cheng HE-Department of Cardiology,School of Medicine,South China University of Technology,Guangzhou,China;Department of Cardiology,Guangdong Cardiovascular Institute,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;The Second School of Clinical Medicine,Southern Medical University,Guangzhou,China;Department of Cardiology,the Second People's Hospital of Nanhai District,Guangdong Provincial People's Hospital's Nanhai Hospital,Foshan,China;De-partment of Biostatistics,School of Public Health,Southern Medical University,Guangzhou,China;Department of Cardiology,Heyuan People's Hospital,Heyuan,China
Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients
Xiaohui Zou;Shengrui Mu;Yeming Wang;Li Guo;Lili Ren;Xiaoyan Deng;Haibo Li;Jiankang Zhao;Yulin Zhang;Hui Li;Binghuai Lu;Chaolin Huang;Bin Cao-Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,National Clinical Research Center for Respiratory Diseases,China-Japan Friendship Hospital,Beijing,100029,China;National Center for Respiratory Medicine,Beijing,100029,China;Institute of Respiratory Medicine,Chinese Academy of Medical Sciences,Beijing,100029,China;Department of Pulmonary and Critical Care Medicine,Capital Medical University,Beijing,100069,China;NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory,Institute of Pathogen Biology,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,100176,China;Jin Yin-tan Hospital,Wuhan,430013,Hubei Province,China;Tsinghua University-Peking University Joint Center for Life Sciences,Beijing,100029,China
Effectiveness of quality of care for patients with type 2 diabetes in China:findings from the Shanghai Integration Model(SIM)
Chun Cai;Yuexing Liu;Yanyun Li;Yan Shi;Haidong Zou;Yuqian Bao;Yun Shen;Xin Cui;Chen Fu;Weiping Jia-Shanghai Diabetes Institute,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,National Office for Primary Diabetes Care,Shanghai Technical Center for Diabetes Prevention and Clinical Care,Shanghai Key Laboratory of Diabetes Mellitus,Department of Endocrinology and Metabolism,Shanghai Clinical Center for Diabetes,Shanghai Key Clinical Center for Metabolic Disease,Shanghai 200233,China;Shanghai Municipal Center for Disease Control&Prevention,Shanghai 200336,China;Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital,Shanghai Key Laboratory of Ocular Fundus Diseases;Shanghai General Hospital, Shanghai Engineering Center for Visual Science and Photomedicine,Shanghai 200040,China;Shanghai Municipal Health Commission Information Center,Shanghai 200040,China
New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria:a prospective cohort study
Jialu Wang;Shanshan Liu;Qiuyu Cao;Shujing Wu;Jingya Niu;Ruizhi Zheng;Lizhan Bie;Zhuojun Xin;Yuanyue Zhu;Shuangyuan Wang;Hong Lin;Tiange Wang;Min Xu;Jieli Lu;Yuhong Chen;Yiping Xu;Weiqing Wang;Guang Ning;Yu Xu;Mian Li;Yufang Bi;Zhiyun Zhao-Department of Endocrine and Metabolic Diseases,Shanghai Institute of Endocrine and Metabolic Diseases,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Shanghai National Clinical Research Center for Metabolic Diseases,Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China,Shanghai Key Laboratory for Endocrine Tumor,State Key Laboratory of Medical Genomics,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Clinical Trials Center,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。